-
NEWS
- January 13, 2009 — Oxygen Biotherapeutics, Inc. announced today that the company’s common stock will begin trading on the NASDAQ Capital Market with the opening of trading on Friday, January 15, 2010. The shares will continue to trade under the symbol OXBT. In addition, company chairman and CEO Chris Stern will be in New York to ring the opening bell at the NASDAQ one week later on Friday, January 22.
Quick Links
New video
This new video looks at Oxycyte™ as a potential treatment for Traumatic Brain Injury and Decompression Sickness.
Interview with Chris Stern CEO
Chairman and CEO Chris Stern talks about the expected duration of the Phase II-b TBI trial in this video.
Follow us on Twitter